Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from MTL Cannabis ( (TSE:MTLC) ) is now available.
MTL Cannabis shareholders have overwhelmingly approved a plan of arrangement under which Canopy Growth will acquire all outstanding MTL Cannabis common shares, clearing a major hurdle for the transaction. The deal, which received more than 99% support from both all shareholders and minority shareholders, is now subject to a final court order and remaining approvals, with closing expected by the end of March 2026, positioning MTL within a larger industry player and potentially reshaping its market reach and strategic direction.
More about MTL Cannabis
MTL Cannabis Corp. is a Canadian cannabis producer and clinic operator whose subsidiaries include Montréal Medical Cannabis in Quebec, Abba Medix in Ontario, IsoCanMed in Quebec, and Canada House Clinics across Canada. The group focuses on craft-quality indoor cannabis flower, pre-rolls and hash for the recreational market, a medical cannabis marketplace and export channels, alongside specialized cannabinoid therapy services for patients.
Average Trading Volume: 160,009
Technical Sentiment Signal: Hold
Current Market Cap: C$69.78M
Find detailed analytics on MTLC stock on TipRanks’ Stock Analysis page.